IRVING, Texas — Veteran McKesson leader, Brian Tyler, has become the company’s new chief executive officer Monday, succeeding John Hammergren. Hammergren has served as the company’s top executive since 1999. “I am incredibly humbled and grateful for the opportunity to lead this company,” said Brian Tyler, chief executive officer, McKesson Corp. “We have a seasoned and talented
SAN FRANCISCO — McKesson Corp. announced that John Hammergren, chairman and chief executive officer, has decided to retire, effective March 31, 2019. McKesson’s board of directors has unanimously selected Brian Tyler, currently president and chief operating officer, to succeed Hammergren as CEO, effective April 1, 2019. Tyler will also remain as president. Edward Mueller, currently
SAN FRANCISCO — McKesson Corp. has named Brian Tyler as president and chief operating officer, effective August 2. He will report to John Hammergren, chairman and chief executive officer, and will become a member of the executive committee. McKesson also announced that Nick Loporcaro, president of McKesson’s U.S. Pharmaceutical and Specialty Solutions segment, has decided
SAN FRANCISCO and TORONTO — McKesson Corp. has closed its $2.1 billion (U.S.) acquisition of Canadian drug chain Rexall Health and hired Domenic Pilla as chief executive officer of McKesson Canada. Earlier this month, McKesson gained clearance from the Competition Bureau of Canada to finalize the Rexall Health acquisition, which was announced in early March.